752570
Last Update Posted: 2015-09-02
Recruiting has ended
All Genders accepted | 18 Years + |
144 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma
This clinical trial will compare the efficacy and safety of the combination of AMG 386 and FOLFIRI with FOLFIRI alone in second line treatment of metastatic colorectal cancer.
Eligibility
Relevant conditions:
Cancer
Carcinoma
Colon Cancer
Colorectal Cancer
Gastrointestinal Cancer
Metastases
Metastatic Cancer
Metastatic Colorectal Cancer
Oncology
Rectal Cancer
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov